Adverse Events Among the Elderly Receiving Chemotherapy for Advanced Non–Small-Cell Lung Cancer

To describe chemotherapy use and adverse events (AEs) for advanced-stage, non-small-cell lung cancer (NSCLC) in community practice, including descriptions according to variation by age. We interviewed patients with newly diagnosed, stages IIIB and IV NSCLC in the population-based cohort studied by t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of clinical oncology 2010-02, Vol.28 (4), p.620-627
Hauptverfasser:	CHRISCHILLES, Elizabeth A, PENDERGAST, Jane F, FLETCHER, Robert H, KAHN, Katherine L, WALLACE, Robert B, MOGA, Daniela C, HARRINGTON, David P, KIEFE, Catarina I, WEEKS, Jane C, WEST, Dee W, ZAFAR, S. Yousuf
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - secondary Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Biological and medical sciences Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - secondary Carcinoma, Squamous Cell - drug therapy Carcinoma, Squamous Cell - secondary Cohort Studies Female Follow-Up Studies Humans Lung Neoplasms - drug therapy Lung Neoplasms - pathology Male Medical sciences Middle Aged Neoplasm Staging Original Reports Pneumology Prognosis Prospective Studies Survival Rate Treatment Outcome Tumors Tumors of the respiratory system and mediastinum
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!